Hugh Watson - Concepedia

Author

Hugh Watson

Sanofi (France)ORCID

Also Known As

H. WATSON, H. Watson, H.R. Watson, Hugh R Watson, Hugh R. Watson, Hugh Watson, Watson, H, Watson, Hugh

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

Sanofi (France)Aarhus University Hospital Universitat de Barcelona Consorci Institut D'Investigacions Biomediques August Pi I Sunyer Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas

About

Hugh Watson is an author at Sanofi (France) specializing in medicine, liver physiology, and hepatology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	849
2	Health Sciences	3	3	116
3	Gastroenterology	2	2	152
4	Diabetes	1	1	70
5	Epidemiology	1	1	70

Hugh Watson

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
Hyponatremia in cirrhosis: Results of a patient population survey Paolo Angeli, Florence Wong, Hugh Watson, Hepatology South AmericaRenal FunctionHepatologyLiver PhysiologySerum Sodium	2006	435
Effects of satavaptan, a selective vasopressin V2 receptor antagonist, on ascites and serum sodium in cirrhosis with hyponatremia Pere Ginès, Florence Wong, Hugh Watson, Hepatology	2008	193
Proton pump inhibitors as a risk factor for hepatic encephalopathy and spontaneous bacterial peritonitis in patients with cirrhosis with ascites Gitte Dam, Hendrik Vilstrup, Hugh Watson, Hepatology	2016	185
Factors related to quality of life in patients with cirrhosis and ascites: Relevance of serum sodium concentration and leg edema Elsa Solà, Hugh Watson, Isabel Graupera, Journal of Hepatology Leg EdemaRenal FunctionHepatologyLiver PhysiologyGastroenterology	2012	139
Satavaptan for the management of ascites in cirrhosis: efficacy and safety across the spectrum of ascites severity Florence Wong, Hugh Watson, Alexander L. Gerbes, Gut	2011	126
Nonselective β‐blockers do not affect mortality in cirrhosis patients with ascites: Post Hoc analysis of three randomized controlled trials with 1198 patients Lars Bossen, Aleksander Krag, Hendrik Vilstrup, Hepatology	2015	119
Effects of a selective vasopressin V2 receptor antagonist, satavaptan, on ascites recurrence after paracentesis in patients with cirrhosis Florence Wong, Pere Ginès, Hugh Watson, Journal of Hepatology HepatologyMedicineLiver PhysiologyPhysiologyHepatitis	2010	83
Diabetes as a risk factor for hepatic encephalopathy in cirrhosis patients Peter Jepsen, Hugh Watson, Per Kragh Andersen, Journal of Hepatology Cirrhosis PatientsHepatic EncephalopathyHepatologyLiver PhysiologyDiabetes	2015	70
Chronic Joint Pain 3 Years after Chikungunya Virus Infection Largely Characterized by Relapsing-remitting Symptoms Sarah R. Tritsch, Liliana Encinales, Nelly Pacheco, The Journal of Rheumatology	2019	70
Stiffness, pain, and joint counts in chronic chikungunya disease: relevance to disability and quality of life Hugh Watson, Sarah R. Tritsch, Liliana Encinales, Clinical Rheumatology	2020	66

Page 1